Please cite this article in press Anjali Maria Thomas et al., Self-Medication Among People Living With Hypertension., Indo Am. J. P. Sci, 2024; 11 (01).

1. World Health Organization. A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis. Geneva, Switzerland: World Health Organization, 2013.
2. World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva, Switzerland: World Health Organization, 2009.
3. Kearney PM, Whelton M, Reynolds K et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217–23.
4. Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755–62.
5. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289:2560–72.
6. World Health Organization. Guidelines for the Regulatory Assessment of Medicinal Products for Use in Self-Medication. WHO/EDM/QSM/00.1. World Health Organization, 2000.
7. Hughes CM, McElnay JC, Fleming GF. Benefits and risks of self medication. Drug Saf 2001; 24: 1027–37.
8. Qato DM, Alexander GC, Conti RM, et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008; 300: 2867–78.
9. Forman JP, Rimm EB, Curhan GC. Frequency of analgesic use and risk of hypertension among men. Arch Intern Med 2007; 167: 394–9.
10. Zheng L, Du X. Non-steroidal anti-inflammatory drugs and hypertension. Cell Biochem Biophys 2014; 69: 209–11.
11. Sclafer J, Slamet LS, de Visscher G. Appropriateness of self-medication: method development and testing in urban Indonesia. J Clin Pharm Ther1997; 22: 261–72.
12. Amoako EP, Richardson-Campbell L, Kennedy-Malone L. Self-medication with over-the-counter drugs among elderly adults. J Gerontol Nurs 2003; 29: 10–5.
13. Grant SJ, Bin YS, Kiat H, Chang DH. The use of complementary and alternative medicine by people with cardiovascular disease: a systematic review. BMC Public Health 2012; 12: 299.
14. Pharand C, Ackman ML, Jackevicius CA et al. Use of OTC and herbal products in patients with cardiovascular disease. Ann Pharmacother 2003; 37: 899–904.
15. Chagan L, Bernstein D, Cheng JW et al. Use of biological based therapy in patients with cardiovascular diseases in a university-hospital in New York City. BMC Complement Altern Med 2005; 5: 4.
16. Gascón JJ, Sánchez-Ortuño M, Llor B, Skidmore D, Saturno PJ. Why hypertensive patients do not comply with the treatment: results from a qualitative study. Fam Pract 2004; 21: 125–30.
17. McBane S, Halstater B. Evaluation of beliefs about hypertension in a general population. J Prim Care Commun Health 2011; 2: 96–9.
18. Liwa AC, Smart LR, Frumkin A et al. Traditional herbal medicine use among hypertensive patients in sub-Saharan Africa: a systematic review. Curr Hypertens Rep 2014; 16: 437.
19. Bennadi D. Self-medication: A current challenge. J Basic Clin Pharm 2013; 5: 19–23.
20. Goh LY, Vitry AI, Semple SJ, Esterman A, Luszcz MA. Self-medication with over-the-counter drugs and complementary medications in South Australia’s elderly population. BMC Complement Altern Med 2009; 9: 42.
21. World Development Indicators. Population Dynamics. 2014. http://data.worldbank.org/indicator/SP.POP.TOTL/countries?display=default(accessed on 27 January 2015).
22. Toprak D, Demir S. Treatment choices of hypertensive patients in Turkey. Behav Med 2007; 33: 5–10.
23. Huang CY, Tsai YT, Lai JN, Hsu FL. Prescription pattern of chinese herbal products for diabetes mellitus in Taiwan: a population-based study. Evid Based Complement Altern Med 2013; 2013: 201329.
24. Balbuena FR, Aranda AB, Figueras A. Self-medication in older urban mexicans: an observational, descriptive, cross-sectional study. Drugs Aging 2009; 26: 51–60.
25. Reyes-Gibby CC, Aday LA. Prevalence of and risk factors for hypertension in a rural area of the Philippines. J Community Health 2000; 25: 389–99.
26. Extavour R, Edwards R. Non‐prescription medicine use by outpatients of a hospital in north‐central Trinidad living with hypertension, and the potential clinical risks. Int J Pharm Pract 2008; 16: 287–93.
27. Neafsey PJ, Jarrín O, Luciano S, Coffman MJ. Self-medication practices of Spanish-speaking older adults in Hartford, Connecticut. Hispanic Health Care Int 2007; 5: 169–79.
28. Neafsey PJ, Shellman J. Adverse self-medication practices of older adults with hypertension attending blood pressure clinics. Internet J Adv Nursing Practice. 2001; 5: 15.
29. Osamor PE, Owumi BE. Complementary and alternative medicine in the management of hypertension in an urban Nigerian community. BMC Complement Altern Med 2010; 10: 36.
30. Nuwaha F, Musinguzi G. Use of alternative medicine for hypertension in Buikwe and Mukono districts of Uganda: a cross sectional study. BMC Complement Altern Med 2013; 13: 301.
31. Hughes GD, Aboyade OM, Clark BL, Puoane TR. The prevalence of traditional herbal medicine use among hypertensives living in South African communities. BMC Complement Altern Med 2013; 13: 38.
32. Wazaify M, Alawwa I, Yasein N, Al-Saleh A, Afifi FU. Complementary and alternative medicine (CAM) use among Jordanian patients with chronic diseases. Complement Ther Clin Pract 2013; 19: 153–7.
33. Eddouks M, Maghrani M, Lemhadri A, Ouahidi ML, Jouad H. Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Tafilalet). J Ethnopharmacol 2002; 82: 97–103.
34. Tilburt JC, Dy SM, Weeks K, Klag M, Young JH. Associations between home remedy use and a validated self-reported adherence measure in an urban African-American population with poorly controlled hypertension. J Natl Med Assoc 2008; 100: 91–7.
35. Bahar Z, Kızılcı S, Beşer A et al. Herbal therapies used by hypertensive patients in Turkey. Afr J Tradit Complement Altern Med 2013; 10 292–8.
36. Olisa NS, Oyelola FT. Evaluation of use of herbal medicines among ambulatory hypertensive patients attending a secondary health care facility in Nigeria. Int J Pharm Pract 2009; 17: 101–5.
37. Tsai DS, Chang YS, Li TC, Peng WH. Prescription pattern of Chinese herbal products for hypertension in Taiwan: a population-based study. J Ethnopharmacol 2014; 155: 1534–40.
38. Mahfudz AS, Chan SC. Use of complementary medicine amongst hypertensive patients in a public primary care clinic in Ipoh. Med J Malaysia 2005; 60: 454–9.
39. Gohar F, Greenfield SM, Beevers DG, Lip GY, Jolly K. Self-care and adherence to medication: a survey in the hypertension outpatient clinic. BMC Complement Altern Med 2008; 8: 4.
40. Bell RA, Suerken CK, Grzywacz JG, Lang W, Quandt SA, Arcury TA. CAM use among older adults age 65 or older with hypertension in the United States: general use and disease treatment. J Altern Complement Med 2006; 12: 903–9.
41. Lee GB, Charn TC, Chew ZH, Ng TP. Complementary and alternative medicine use in patients with chronic diseases in primary care is associated with perceived quality of care and cultural beliefs. Fam Pract 2004; 21: 654–60.
42. Anderson JG, Taylor AG. Use of complementary therapies by individuals with or at risk for cardiovascular disease: results of the 2007 National Health Interview Survey. J Cardiovasc Nurs 2012; 27: 96–102.
43. Hu H, Li G, Duan J, Arao T. Prevalence, purposes, and perceived effectiveness of complementary and alternative medicine use in a hypertension population: a questionnaire survey. ISRN Public Health. 2013. doi:10.1155/2013/137472:1-7.
44. Peltzer K. Health beliefs and prescription medication compliance among diagnosed hypertension clinic attenders in a rural South African Hospital. Curationis 2004; 27: 15–23.
45. Mollaoğlu M, Aciyurt A. Use of complementary and alternative medicine among patients with chronic diseases. Acta Clin Croat 2013; 52: 181–8.
46. Shafiq N, Gupta M, Kumari S, Pandhi P. Prevalence and pattern of use of complementary and alternative medicine (CAM) in hypertensive patients of a tertiary care center in India. Int J Clin Pharmacol Ther 2003; 41: 294–8.
47. Amira OC, Okubadejo NU. Frequency of complementary and alternative medicine utilization in hypertensive patients attending an urban tertiary care centre in Nigeria. BMC Complement Altern Med 2007; 7: 30.
48. Ali-Shtayeh MS, Jamous RM, Jamous RM, Salameh NM. Complementary and alternative medicine (CAM) use among hypertensive patients in Palestine. Complement Ther Clin Pract 2013; 19: 256–63.
49. Kretchy IA, Owusu-Daaku F, Danquah S. Patterns and determinants of the use of complementary and alternative medicine: a cross-sectional study of hypertensive patients in Ghana. BMC Complement Altern Med 2014; 14: 44.
50. Frass M, Strassl RP, Friehs H, Müllner M, Kundi M, Kaye AD. Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner J 2012; 12: 45–56.
51. Llor C, Cots JM. The sale of antibiotics without prescription in pharmacies in Catalonia, Spain. Clin Infect Dis 2009; 48: 1345–9.
52. Volpato DE, de Souza BV, Dalla Rosa LG, Melo LH, Daudt CA, Deboni L. Use of antibiotics without medical prescription. Braz J Infect Dis 2005; 9: 288–91.
53. Al-Mohamadi A, Badr A, Bin Mahfouz L, Samargandi D, Al Ahdal A. Dispensing medications without prescription at Saudi community pharmacy: Extent and perception. Saudi Pharm J 2013; 21: 13–8.
54. World Health Organization. The Role of the pharmacist in self-care and self-medication: report of the 4th WHO Consultative Group on the Role of the Pharmacist. The Hague, The Netherlands. http://apps.who.int/medicinedocs/pdf/whozip32e/whozip32e.pdf (accessed on 6 February 2015).
55. World Health Organization. Self-care in the context of primary healthcare. Report of the Regional Consultation, Bangkok, Thailand. http://apps.searo.who.int/PDS_DOCS/B4301.pdf (accessed on 24 January 2015).
56. Suryawati S. CBIA: Improving the quality of self-medication through mothers’ active learning. Essential Drugs Monitor World Health Organization Geneva. 2003; 32: 22–3.
57. Rabito MJ, Kaye AD. Complementary and alternative medicine and cardiovascular disease: an evidence-based review. Evid Based Complement Alternat Med 2013; 2013: 672097.
58. Fischer FH, Lewith G, Witt CM et al. High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research. BMC Complement Altern Med 2014; 14: 46.
59. Borrelli F, Capasso R, Izzo AA. Garlic (Allium sativum L.): adverse effects and drug interactions in humans. Mol Nutr Food Res 2007; 51: 1386–97.
60. Shelley BM, Sussman AL, Williams RL, Segal AR, Crabtree BF. ‘They don’t ask me so I don’t tell them’: patient-clinician communication about traditional, complementary, and alternative medicine. Ann Fam Med 2009; 7: 139–47.
61. Clement YN, Williams AF, Khan K et al. A gap between acceptance and knowledge of herbal remedies by physicians: the need for educational intervention. BMC Complement Altern Med 2005; 5: 20.